Li-cadherin is inversely correlated with Galectin-3 expression in gastric cancer

被引：35
作者：
Dong, Wei-Guo [1 ]
Yu, Qiong-Fang [1 ]
Xu, Yu [2 ]
Fan, Li-Fang [3 ]
机构：
[1] Wuhan Univ, Renmin Hosp, Dept Gastroenterol, Wuhan 430060, Peoples R China
[2] Wuhan Univ, Renmin Hosp, Dept Otolaryngol Head & Neck Surg, Wuhan 430060, Peoples R China
[3] Wuhan Univ, Sch Med, Dept Pathol, Wuhan 430060, Peoples R China
来源：
DIGESTIVE DISEASES AND SCIENCES | 2008年 / 53卷 / 07期
关键词：
gastric cancer; Li-cadherin; Galectin-3; immunohistochemistry; semiquantitative polymerase chain reaction;
D O I：
10.1007/s10620-007-0080-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
The aims of this study were to examine the expressions of Li-cadherin and Galectin-3 in gastric cancer, and the correlation between Li-cadherin and Galectin-3 in gastric cancer was also analyzed. The present study investigated the expression level of Li-cadherin and Galectin-3 by immunohistochemistry and semiquantitative polymerase chain reaction (PCR), and correlated this with clinicopathologic parameters in 91 cases of gastric cancer. The correlation between expression levels of Li-cadherin and Galectin-3 was analyzed by Spearman correlation analysis. The expression level of Li-cadherin mRNA was correlated to differentiation and lymph node metastasis, and the expression level of Galectin-3 was related to TNM staging, differentiation and lymph node metastasis. On Spearman correlation analysis, a definitive negative correlation was found between the expression levels of Li-cadherin and Galectin-3 in gastric cancerous tissues. We postulate that interaction between Li-cadherin and Galectin-3 may play an important role in the development of gastric cancer.
引用
收藏
页码：1811 / 1817
页数：7
相关论文
共 44 条
[1]   Increased galectin-3 expression in gastric cancer:: Correlations with histopathological subtypes, galactosylated antigens and tumor cell proliferation [J].
Baldus, SE ;
Zirbes, TK ;
Weingarten, M ;
Fromm, S ;
Glossmann, J ;
Hanisch, FG ;
Mönig, SP ;
Schröder, W ;
Flucke, U ;
Thiele, J ;
Hölscher, AH ;
Dienes, HP .
TUMOR BIOLOGY, 2000, 21 (05) :258-266
[2]   Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions [J].
Bartolazzi, A ;
Gasbarri, A ;
Papotti, M ;
Bussolati, G ;
Lucante, T ;
Khan, A ;
Inohara, H ;
Marandino, F ;
Orlandi, F ;
Nardi, F ;
Vecchione, A ;
Tecce, R ;
Larsson, O .
LANCET, 2001, 357 (9269) :1644-1650
[3]   LIVER-INTESTINE CADHERIN - MOLECULAR-CLONING AND CHARACTERIZATION OF A NOVEL CA2+-DEPENDENT CELL-ADHESION MOLECULE EXPRESSED IN LIVER AND INTESTINE [J].
BERNDORFF, D ;
GESSNER, R ;
KREFT, B ;
SCHNOY, N ;
LAJOUSPETTER, AM ;
LOCH, N ;
REUTTER, W ;
HORTSCH, M ;
TAUBER, R .
JOURNAL OF CELL BIOLOGY, 1994, 125 (06) :1353-1369
[4]   A circulating ligand for galectin-3 glycoprotein elevated in individual is a haptoglobin-related with colon cancer [J].
Bresalier, RS ;
Byrd, JC ;
Tessler, D ;
Lebel, J ;
Koomen, J ;
Hawke, D ;
Half, E ;
Liu, KF ;
Mazurek, N .
GASTROENTEROLOGY, 2004, 127 (03) :741-748
[5]   Galectin-3: differential expression between small-cell and non-small-cell lung cancer [J].
Buttery, R ;
Monaghan, H ;
Salter, DM ;
Sethi, T .
HISTOPATHOLOGY, 2004, 44 (04) :339-344
[6]  
Castronovo V, 1996, J PATHOL, V179, P43, DOI 10.1002/(SICI)1096-9896(199605)179:1<43::AID-PATH541>3.0.CO
[7]  
2-N
[8]   Inhibition of N-(4-hydroxyphenyl) retinamide-induced apoptosis in breast cancer cells by galectin-3 [J].
Choi, JH ;
Chun, KH ;
Raz, A ;
Hong, WK ;
Lotan, R .
CANCER BIOLOGY & THERAPY, 2004, 3 (05) :447-452
[9]  
Chung EJ, 2002, MOL CELLS, V14, P382
[10]   Galectin-3 and carcinoembryonic antigen expression in medullary thyroid carcinoma: possible relation to tumour progression [J].
Cvejic, D ;
Savin, S ;
Golubovic, S ;
Paunovic, I ;
Tatic, S ;
Havelka, M .
HISTOPATHOLOGY, 2000, 37 (06) :530-535
12345